
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 278122
[patent_doc_number] => 07557198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-07
[patent_title] => 'Acute myelogenous leukemia biomarkers'
[patent_app_type] => utility
[patent_app_number] => 11/417450
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10920
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/557/07557198.pdf
[firstpage_image] =>[orig_patent_app_number] => 11417450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/417450 | Acute myelogenous leukemia biomarkers | May 2, 2006 | Issued |
Array
(
[id] => 9621064
[patent_doc_number] => 08791237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Compositions and methods for treatment of non-hodgkins lymphoma'
[patent_app_type] => utility
[patent_app_number] => 11/415271
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 45
[patent_no_of_words] => 24361
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11415271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/415271 | Compositions and methods for treatment of non-hodgkins lymphoma | May 1, 2006 | Issued |
Array
(
[id] => 5620259
[patent_doc_number] => 20060189793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Methods and compositions for inhibiting neoplastic cell growth'
[patent_app_type] => utility
[patent_app_number] => 11/412373
[patent_app_country] => US
[patent_app_date] => 2006-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 87023
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11412373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/412373 | Methods and compositions for inhibiting neoplastic cell growth | Apr 26, 2006 | Abandoned |
Array
(
[id] => 5784277
[patent_doc_number] => 20060204483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Cellular telomerase vaccine and its use for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/413838
[patent_app_country] => US
[patent_app_date] => 2006-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6084
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413838 | Cellular telomerase vaccine and its use for treating cancer | Apr 26, 2006 | Issued |
Array
(
[id] => 7515137
[patent_doc_number] => 08039208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Automated strategy for identifying physiological glycosylation markers(s)'
[patent_app_type] => utility
[patent_app_number] => 11/411232
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 20875
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411232 | Automated strategy for identifying physiological glycosylation markers(s) | Apr 25, 2006 | Issued |
Array
(
[id] => 4455508
[patent_doc_number] => 07892752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Glycosylation markers for cancer diagnosing and monitoring'
[patent_app_type] => utility
[patent_app_number] => 11/411246
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 16883
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411246
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411246 | Glycosylation markers for cancer diagnosing and monitoring | Apr 25, 2006 | Issued |
Array
(
[id] => 5619420
[patent_doc_number] => 20060188953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Methods and compositions that affect melanogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/408108
[patent_app_country] => US
[patent_app_date] => 2006-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 36572
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188953.pdf
[firstpage_image] =>[orig_patent_app_number] => 11408108
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/408108 | Methods and compositions that affect melanogenesis | Apr 19, 2006 | Issued |
Array
(
[id] => 5888839
[patent_doc_number] => 20060275844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Diagnostic markers of breast cancer treatment and progression and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/407169
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23872
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275844.pdf
[firstpage_image] =>[orig_patent_app_number] => 11407169
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/407169 | Diagnostic markers of breast cancer treatment and progression and methods of use thereof | Apr 17, 2006 | Abandoned |
Array
(
[id] => 5204943
[patent_doc_number] => 20070026424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Gene profiles correlating with histology and prognosis'
[patent_app_type] => utility
[patent_app_number] => 11/404715
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12515
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026424.pdf
[firstpage_image] =>[orig_patent_app_number] => 11404715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/404715 | Gene profiles correlating with histology and prognosis | Apr 13, 2006 | Abandoned |
Array
(
[id] => 6630445
[patent_doc_number] => 20100035244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Diagnostic for lung disorders using class prediction'
[patent_app_type] => utility
[patent_app_number] => 11/918588
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 32124
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918588
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918588 | Diagnostic for lung disorders using class prediction | Apr 13, 2006 | Abandoned |
Array
(
[id] => 5508442
[patent_doc_number] => 20090081649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Diagnostic method for detecting cancer by measuring amount of cytokine like il -6'
[patent_app_type] => utility
[patent_app_number] => 11/918488
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4536
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081649.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918488 | Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6 | Apr 11, 2006 | Issued |
Array
(
[id] => 4498782
[patent_doc_number] => 07919246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'SEMA4D in cancer diagnosis, detection and treatment'
[patent_app_type] => utility
[patent_app_number] => 11/918179
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 53178
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919246.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918179
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918179 | SEMA4D in cancer diagnosis, detection and treatment | Apr 6, 2006 | Issued |
Array
(
[id] => 5834661
[patent_doc_number] => 20060246492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Method for predicting responsiveness to drugs'
[patent_app_type] => utility
[patent_app_number] => 11/398413
[patent_app_country] => US
[patent_app_date] => 2006-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16806
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398413
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398413 | Method for predicting responsiveness to drugs | Apr 4, 2006 | Abandoned |
Array
(
[id] => 5753947
[patent_doc_number] => 20060223096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function'
[patent_app_type] => utility
[patent_app_number] => 11/388204
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33052
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223096.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388204
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388204 | Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function | Mar 23, 2006 | Abandoned |
Array
(
[id] => 4669348
[patent_doc_number] => 20080044408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63'
[patent_app_type] => utility
[patent_app_number] => 11/387007
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 26426
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11387007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/387007 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Mar 21, 2006 | Abandoned |
Array
(
[id] => 5759529
[patent_doc_number] => 20060210474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63'
[patent_app_type] => utility
[patent_app_number] => 11/367798
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 26388
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11367798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/367798 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5204432
[patent_doc_number] => 20070025912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63'
[patent_app_type] => utility
[patent_app_number] => 11/362452
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 31868
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20070025912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11362452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/362452 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Feb 23, 2006 | Issued |
Array
(
[id] => 7535366
[patent_doc_number] => 08048992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Anti-IgSF4 antibody and utilization of the same'
[patent_app_type] => utility
[patent_app_number] => 11/885245
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 41725
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048992.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885245 | Anti-IgSF4 antibody and utilization of the same | Feb 21, 2006 | Issued |
Array
(
[id] => 6320416
[patent_doc_number] => 20100196358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'METHOD AND KIT TO PROFILE TUMORS BY BIOMARKER ANALYSES INCLUDING TRANSCRIPTIONAL FACTOR ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 11/816392
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12143
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196358.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816392 | METHOD AND KIT TO PROFILE TUMORS BY BIOMARKER ANALYSES INCLUDING TRANSCRIPTIONAL FACTOR ASSAYS | Feb 15, 2006 | Abandoned |
Array
(
[id] => 903655
[patent_doc_number] => 07335738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Heregulin-like factor'
[patent_app_type] => utility
[patent_app_number] => 11/354079
[patent_app_country] => US
[patent_app_date] => 2006-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 38551
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11354079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/354079 | Heregulin-like factor | Feb 14, 2006 | Issued |